Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 12,000 shares at $30.34 ($364K) on 2017-08-07, disclosed to the SEC on 2017-08-09.
Open-market sale of $364k JUNO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |